financetom
Business
financetom
/
Business
/
Kering warns of 10% first-quarter revenue slide
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kering warns of 10% first-quarter revenue slide
Mar 19, 2024 11:09 AM

(Reuters) - Luxury goods group Kering warned on Tuesday that its first-quarter sales are likely to drop by around 10%, weighed down by star label Gucci, knocking back hopes that it had stemmed sales declines.

Citing a "steeper sales drop" at Gucci in the Asia-Pacific region, the group said that the fashion brand's comparable quarterly revenue is projected to slide by nearly 20% year on year.

Kering in February announced plans to invest in Gucci this year, with margins likely to be dented as a result.

Early products from the label's Ancora collection, which have been in some stores since mid-February, have been well received, the company said on Tuesday.

The group reports first-quarter sales on April 23.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sezzle Insider Sold Shares Worth $3,029,506, According to a Recent SEC Filing
Sezzle Insider Sold Shares Worth $3,029,506, According to a Recent SEC Filing
Aug 12, 2024
10:42 AM EDT, 08/12/2024 (MT Newswires) -- Paul Martin Purcell, Former Director, on August 08, 2024, sold 30,010 shares in Sezzle ( SEZL ) for $3,029,506. Following the Form 4 filing with the SEC, Purcell has control over a total of 314,640 shares of the company, with 314,640 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1662991/000186499124000026/xslF345X03/primary_doc.xml Price: 111.66, Change: -4.75, Percent Change:...
Draftkings Insider Sold Shares Worth $6,144,000, According to a Recent SEC Filing
Draftkings Insider Sold Shares Worth $6,144,000, According to a Recent SEC Filing
Aug 12, 2024
10:38 AM EDT, 08/12/2024 (MT Newswires) -- Jason Robins, Director, Chief Executive Officer and Chairman of the Board, on August 08, 2024, sold 200,000 shares in Draftkings ( DKNG ) for $6,144,000. Following the Form 4 filing with the SEC, Robins has control over a total of 2,703,056 shares of the company, with 2,699,815 shares held directly and 3,241 controlled...
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Aug 12, 2024
Monday, the FDA approved Ascendis Pharma A/S’ Yorvipath (palopegteriparatide; developed as TransCon PTH) for hypoparathyroidism in adults. Hypoparathyroidism is a rare, treatable condition that occurs when a person has low levels of parathyroid hormone in the blood. This causes low calcium levels (hypocalcemia) and high phosphorous levels. Also Read: Ascendis Pharma’s Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial. Hypoparathyroidism impacts multiple...
Huntington Ingalls Secures $209 Million Air Force Weapons Systems Contract
Huntington Ingalls Secures $209 Million Air Force Weapons Systems Contract
Aug 12, 2024
10:43 AM EDT, 08/12/2024 (MT Newswires) -- Huntington Ingalls Industries' ( HII ) Mission Technologies division has secured a $209 million contract for a five-year task order to support the development and sustainment of the US Air Force's fighter and bomber weapons systems through research and analysis, HII said Monday. Huntington Ingalls shares were up more than 1% in recent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved